429 related articles for article (PubMed ID: 16869769)
1. Epigenetic changes in cancer and preneoplasia.
Herman JG
Cold Spring Harb Symp Quant Biol; 2005; 70():329-33. PubMed ID: 16869769
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation differences associated with tumor tissues identified by genome scanning analysis.
Liang G; Salem CE; Yu MC; Nguyen HD; Gonzales FA; Nguyen TT; Nichols PW; Jones PA
Genomics; 1998 Nov; 53(3):260-8. PubMed ID: 9799591
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation and gene silencing in cancer: which is the guilty party?
Clark SJ; Melki J
Oncogene; 2002 Aug; 21(35):5380-7. PubMed ID: 12154400
[TBL] [Abstract][Full Text] [Related]
4. DNA hypermethylation: when tumour suppressor genes go silent.
Garinis GA; Patrinos GP; Spanakis NE; Menounos PG
Hum Genet; 2002 Aug; 111(2):115-27. PubMed ID: 12189484
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic changes in cancer.
Grønbaek K; Hother C; Jones PA
APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation status of multiple genes in uveal melanoma.
Merhavi E; Cohen Y; Avraham BC; Frenkel S; Chowers I; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4403-6. PubMed ID: 17898258
[TBL] [Abstract][Full Text] [Related]
7. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis.
Clark SJ
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R88-95. PubMed ID: 17613553
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic changes in solid and hematopoietic tumors.
Toyota M; Issa JP
Semin Oncol; 2005 Oct; 32(5):521-30. PubMed ID: 16210093
[TBL] [Abstract][Full Text] [Related]
9. Review of genetic and epigenetic alterations in hepatocarcinogenesis.
Herath NI; Leggett BA; MacDonald GA
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):15-21. PubMed ID: 16706806
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation: the nuts and bolts of repression.
Miranda TB; Jones PA
J Cell Physiol; 2007 Nov; 213(2):384-90. PubMed ID: 17708532
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation, chromatin inheritance, and cancer.
Rountree MR; Bachman KE; Herman JG; Baylin SB
Oncogene; 2001 May; 20(24):3156-65. PubMed ID: 11420732
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker.
Teodoridis JM; Strathdee G; Brown R
Drug Resist Updat; 2004; 7(4-5):267-78. PubMed ID: 15533764
[TBL] [Abstract][Full Text] [Related]
13. Methylation of estrogen receptor beta promoter correlates with loss of ER-beta expression in mammary carcinoma and is an early indication marker in premalignant lesions.
Rody A; Holtrich U; Solbach C; Kourtis K; von Minckwitz G; Engels K; Kissler S; Gätje R; Karn T; Kaufmann M
Endocr Relat Cancer; 2005 Dec; 12(4):903-16. PubMed ID: 16322330
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
15. Gene silencing by DNA methylation in haematological malignancies.
Boultwood J; Wainscoat JS
Br J Haematol; 2007 Jul; 138(1):3-11. PubMed ID: 17489980
[TBL] [Abstract][Full Text] [Related]
16. The role of epigenetic inactivation of 14-3-3sigma in human cancer.
Lodygin D; Hermeking H
Cell Res; 2005 Apr; 15(4):237-46. PubMed ID: 15857578
[TBL] [Abstract][Full Text] [Related]
17. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours.
Esteller M; Herman JG
J Pathol; 2002 Jan; 196(1):1-7. PubMed ID: 11748635
[TBL] [Abstract][Full Text] [Related]
18. Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growth.
Hong C; Moorefield KS; Jun P; Aldape KD; Kharbanda S; Phillips HS; Costello JF
Proc Natl Acad Sci U S A; 2007 Jun; 104(26):10974-9. PubMed ID: 17578925
[TBL] [Abstract][Full Text] [Related]
19. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
Baylin SB; Ohm JE
Nat Rev Cancer; 2006 Feb; 6(2):107-16. PubMed ID: 16491070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]